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Purpura haemorrhagica is an immune-mediated, aseptic necro-
tizing vasculitis caused by immune complex deposition (type III
hypersensitivity reaction) in the vascular endothelium, which can
occur after Streptococcus equi subsp. equi (S. equi) infection or
vaccination. Metastatic spread of S. equi is also a frequent
complication, which can lead to suppurative inﬂammation such as
bronchopneumonia, nephritis, hepatitis, splenitis, lymphadenitis,
arthritis, and others. This study describes the clinical, microbio-
logical, post-mortem, and histological ﬁndings in a presumptive
case of purpura haemorrhagica with simultaneous metastatic
spread that occurred in a six-month-old Thoroughbred foal. The
case described occurred among a population of 110 weanlings on
a breeding farm located in Buenos Aires, Argentinawith history of
sporadic occurrence of strangles among vaccinated foals. During
the 2010 and 2011 foaling seasons, two foals developed a clinical
syndrome characterized by subcutaneous limb edema affecting
the four limbs and extending to the carpus and hock, weight loss,
lethargy, and forelimb bilateral hyperextension of the fetlock and
pastern joints. Both foals were humanely euthanized and no
etiological diagnosis could be determined at that time. In 2013, a
6-month old foal developed similar clinical signs 60 days after
re-vaccination with an autogenous S. equi bacterin. Clinical signs
included fever, weight loss, lethargy, mucopurulent nasal
discharge, limb edema, and bilateral hyperextension of fetlock
and pastern joints with no favorable response to treatment.
Laboratory tests demonstrated leukocytosis and neutrophilia,
hyperﬁbrinogenaemia, azotaemia and hypoproteinaemia. Post-
mortem ﬁndings included pericardial and abdominal effusions,
renomegaly, mild splenomegaly and bilateral necrotizing
tendonitis of the deep digital ﬂexor tendon. Even though
lymphadenitis or abnormal content within guttural pouches were
not observed, S. equi was isolated from guttural pouch swabs.
However, the antibiotic treatment could have potentially hin-
dered the isolation of S. equi from other organs (spleen, liver and
lung). Histopathological lesions included suppurative necrotizing
tendonitis associated with vasculitis, thrombosis and presence of
bacterial colonies, focal suppurative bronchopneumonia and
ﬁbrinoid vasculitis, non-suppurative interstitial nephritis with
presence of hyaline cylinders or necrotic exudates and thickening
of the glomerular basement membrane due to protein deposition
(Masson’s trichrome stain), and suppurative pyelonephritis. The
epidemiological, clinical and microbiological data together with
the post-mortem and histologic ﬁndings are consistentwith other
reports of type III hypersensitivity reaction in foals and adult
horses and metastatic spread of S. equi and seeding of multipleorgans. However, the acute and severe tendon and renal lesions
observed were not prominently characterized in previous reports
of the disease. Even though rare, the clinical signs and lesions
described here should be taken into consideration in the diagnosis
and outcome of S. equi infection.
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Streptococcus equi subspecies equi (S. equi) is the causal agent of
strangles, a highly contagious infectious disease of horses charac-
terised by abscessation of the lymph nodes of the head and neck,
fever and mucopurulent nasal discharge(1). The putative phos-
pholipase A2 toxins SlaA and SlaB are thought to be pathogenic
factors thathydrolysephospholipids andare likely tobe involved in
the disruption of eukaryotic cell membranes and invasion of the
host(2). SlaA contributes to the virulence of Streptococcus pyogenes
(S. pyogenes) and is associated with increased morbidity and
mortalityofhumans(3). The slaAgene is carriedbyaprophage and is
widely distributed amongst isolates of S. equi (26/26) and Strepto-
coccus zooepidemicus (S. zooepidemicus) (44/140)(4). The genomes
of S. equi and S. zooepidemicus encode a second putative phos-
pholipase A2 toxin, SlaB, which shares 70% predicted amino acid
sequence identity with SlaA of S. pyogenes(4). Despite their ho-
mology with SlaA from S. pyogenes, the activity of phospholipases
produced by S. equi and S. zooepidemicus have not been studied yet.
The present work aimed to clone, express and produce recombi-
nant SlaA and SlaB proteins from S. equi strain 4047 (Se4047) and a
variant of SlaB from S. zooepidemicus strain H70 (SzH70). The
enzymatic activity of puriﬁed recombinant proteins and their po-
tential effect on the immune response were also evaluated. slaA
and slaB genes from Se4047 and SzH70 strains were cloned as
glutathione S-transferase (GST) fusions using a pGEX-3X vector.
The activities of recombinant SlaA (rSla) and SlaB (rSlaB) were
measured using the EnzChek Phospholipase A2 kit. Their inﬂuence
on the immune response was determined through cell prolifera-
tion assays measuring the incorporation of 3H-Thymidine. rSlaA
and rSlaB from S. equi and S. zooepidemicus were successfully
produced. rSlaA from Se4047 and rSlaB from SzH70 had phospho-
lipase activity (2.33 U/mg and 5.13 U/mg, respectively). However,
no enzymatic activity was detected for rSlaB Se4047. Proliferation
of equine macrophages was signiﬁcantly higher following stimu-
lationwith 0.6 to 0.06mg/ml of SlaB from SzH70 orwith 0.6mg/ml
of SlaAwhen compared tounstimulated controls. In conclusion,we
produced three recombinant phospholipase A2 toxins from S. equi
and S. zooepidemicus. Preliminary results indicate that two of them
are enzymatically active and induce low levels of proliferation of
equine immune cells. These preliminary results support that SlaA
andSlaBmaycontribute to the abilityof S. equiand S. zooepidemicus
to infect and cause disease in horses which warrant further
investigation into their speciﬁc role as pathogenic factors.References
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